SecBot SecBot
EFFECT ·Filed May 22, 2026

HYPR

Hyperfine, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC9999999995-26-001730
IPO/offering going effective
Actionable Insight • Neutral

The effective shelf creates a modest overhang of up to ~1.1M shares (less than 1% of float), but the registration is for existing warrant shares, not a new offering. Monitor for any subsequent takedown notice or prospectus supplement that would signal actual selling. The strong Q1 results and extended cash runway reduce the likelihood of a distress-driven offering.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HYPR ▼ -39.89% at T+60d
NEUTRAL call -39.89% · α vs SPY -43.08% · entry $1.49 → $0.8957
Entry = T+0 close
May 22, 2026
via day close
T+1d
+11.41%
call +11.41% · α +10.82%
$1.66
settled 5mo ago
T+5d
+2.01%
call +2.01% · α +0.36%
$1.52
settled 5mo ago
T+20d
-0.27%
call -0.27% · α +1.15%
$1.49
settled 4mo ago
T+60d
-39.89%
call -39.89% · α -43.08%
$0.8957
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Hyperfine's S-3 shelf registration (File No. 333-295807) became effective on May 21, 2026, enabling the resale of 1,083,335 shares of Class A common stock by Horizon Technology Finance affiliates. These shares were issued as warrants in a $15.0M debt financing in March 2026, and the company will receive up to ~$1.3M only if the warrants are exercised for cash. The effectiveness is a routine procedural step tied to contractual registration rights, not a new capital raise, and follows strong Q1 2026 earnings (revenue up 83% YoY).

Key Facts

  • S-3 shelf registration (333-295807) became effective on May 21, 2026.
  • Registration covers 1,083,335 shares of Class A common stock for resale by Horizon Technology Finance affiliates.
  • Shares were issued as warrants in a $15.0M debt financing from March 2026.
  • Company receives up to ~$1.3M only if warrants are exercised for cash.
  • Q1 2026 revenue grew 83% YoY to $3.90M; net loss narrowed to $8.62M.
  • Cash runway extended into 2028 per prior S-3 filing context.

Financial Impact

Up to ~$1.3M in potential cash proceeds if warrants are exercised; no immediate dilution from the shelf itself.

dilutioncash

Risk Factors

  • Potential dilution if warrant holders exercise and sell into the market.
  • Shelf could be used for future offerings if the company's cash position deteriorates.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001730
Document: 9999999995-26-001730-index.html9999999995-26-001730
Document: 9999999995-26-001730.txt9999999995-26-001730
5 reports for HYPR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HYPR — sortable, filterable
TypeNow
Oct 8, 2026
18d ago
8-K
BULLISH ★ 6/10
$0.9401 $0.7801▼ −17.02%▼ −16.74%$0.7230 (−23.09%)
May 22, 2026
22w ago
EFFECT
NEUTRAL ★ 4/10
$1.49 $1.52▲ +2.01%▲ +0.36%$0.7230 (−51.48%)
May 12, 2026
23w ago
S-3
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −10.16%$0.7230 (−54.53%)
Apr 8, 2026
28w ago
DEFA14A
NEUTRAL ★ 2/10
$1.21 $1.33▲ +9.92%▲ +6.73%$0.7230 (−40.25%)
Mar 23, 2026
31w ago
Insider Cluster
BEARISH ★ 5/10
$1.21 $1.03▲ +14.88%▲ +11.31%$0.7230 (+40.25%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 2h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026